Besides, our study showed that EGFR mutation was associated with less lymphadenopathy and less lymph node metastasis pathologically, supporting a previous study13, suggesting a lower invasiveness of tumours with EGFR mutations. This evidence concerns the gene EGFR and metastatic malignant neoplasm in the lymph nodes.